Deal Of The Week: Will Heated Competition To Buy Out Ache Laboratorios Muddy The Brazilian Waters?
This article was originally published in PharmAsia News
Executive Summary
Pfizer, Novartis and Abbott reportedly are battling to buy out family-owned Ache, Brazil’s leader in prescription drug sales.